Copper radiopharmaceuticals for theranostic applications

被引:54
作者
Ahmedova, Anife [1 ]
Todorov, Boyan [1 ]
Burdzhiev, Nikola [1 ]
Goze, Christine [2 ]
机构
[1] Sofia Univ, Fac Chem & Pharm, 1 J Bourchier Ave, Sofia 1164, Bulgaria
[2] Univ Bourgogne, ICMUB, Team P2DA, UMR CNRS 6302, F-21000 Dijon, France
基金
欧盟地平线“2020”;
关键词
Copper radionuclides; Theranostics; Radiopharmaceuticals; Radioimaging; Radiotherapy; Copper chelators; CU-62-DIACETYL-BIS N-4-METHYLTHIOSEMICARBAZONE PET; CLICK-CHEMISTRY STRATEGY; ASSESSING TUMOR HYPOXIA; TARGETED DRUG-DELIVERY; IN-VIVO BEHAVIOR; SMALL-ANIMAL PET; BIOLOGICAL EVALUATION; BIFUNCTIONAL CHELATOR; BREAST-CANCER; ZN-62/CU-62; GENERATOR;
D O I
10.1016/j.ejmech.2018.08.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The growing advancement in nuclear medicine challenges researchers from several different fields to integrate imaging and therapeutic modalities in a theranostic radiopharmaceutical, which can be defined as a molecular entity with readily replaceable radioisotope to provide easy switch between diagnostic and therapeutic applications for efficient and patient-friendly treatment of diseases. For such a reason, the diagnostic and therapeutic potential of all five medical radionuclides of copper have thoroughly been investigated as they boost the hope for development of successful radiotheranostics. To facilitate the mutual understanding between all different specialists working on this multidisciplinary field, we summarized the recent updates in copper-based nuclear medicine, with specific attention to the potential theranostic applications. Thereby, this review paper is focused on the current achievements in the copper-related complementary fields, such as synthetic and nuclear chemistry, biological assessment of radiopharmaceuticals, design and development of nanomaterials for multimodal theranostic implications. This work includes: i) description of available copper radionuclide production methods; ii) analyses of the synthetic strategies for development of improved copper radiopharmaceuticals; iii) summary of reported clinical data and recent preclinical studies from the last five years on biological applicability of copper radiopharmaceuticals; and iv) illustration of some sophisticated multimodal nanotheranostic agents that comprise several imaging and therapeutic modalities. Significant advancement can be seen in the synthetic procedures, which enables the broader implication of pretargeting approaches via bio-orthogonal click reactions, as well as in the nanotechnology methods for biomimetic construction of biocompatible multimodal copper theranostics. All this gives the hope that personalized treatment of various diseases can be achieved by copper theranostics in the near future. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1406 / 1425
页数:20
相关论文
共 194 条
[1]  
Abadjian M-C Z., 2017, DESIGN APPL NANOPART, P229
[2]   A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer [J].
Adumeau, Pierre ;
Carnazza, Kathryn E. ;
Brand, Christian ;
Carlin, Sean D. ;
Reiner, Thomas ;
Agnew, Brian J. ;
Lewis, Jason S. ;
Zeglis, Brian M. .
THERANOSTICS, 2016, 6 (12) :2267-2277
[3]   Site-Specifically Labeled Immunoconjugates for Molecular Imaging-Part 2: Peptide Tags and Unnatural Amino Acids [J].
Adumeau, Pierre ;
Sharma, Sai Kiran ;
Brent, Colleen ;
Zeglis, Brian M. .
MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (02) :153-165
[4]   Site-Specifically Labeled Immunoconjugates for Molecular Imaging-Part 1: Cysteine Residues and Glycans [J].
Adumeau, Pierre ;
Sharma, Sai Kiran ;
Brent, Colleen ;
Zeglis, Brian M. .
MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (01) :1-17
[5]   Evaluation of 64Cu-Labeled Bifunctional Chelate-Bombesin Conjugates [J].
Ait-Mohand, Samia ;
Fournier, Patrick ;
Dumulon-Perreault, Veronique ;
Kiefer, Garry E. ;
Jurek, Paul ;
Ferreira, Cara L. ;
Benard, Francois ;
Guerin, Brigitte .
BIOCONJUGATE CHEMISTRY, 2011, 22 (08) :1729-1735
[6]   One step purification process for no-carrier-added 64Cu produced using enriched nickel target [J].
Alliot, C. ;
Michel, N. ;
Bonraisin, A. -C. ;
Bosse, V. ;
Laize, J. ;
Bourdeau, C. ;
Mokili, B. M. ;
Haddad, F. .
RADIOCHIMICA ACTA, 2011, 99 (10) :627-630
[7]   Single-Chain Antibody Conjugated to a Cage Amine Chelator and Labeled with Positron-Emitting Copper-64 for Diagnostic Imaging of Activated Platelets [J].
Alt, Karen ;
Paterson, Brett M. ;
Ardipradja, Katie ;
Schieber, Christine ;
Buncic, Gojko ;
Lim, Bock ;
Poniger, Stan S. ;
Jakoby, Bjoern ;
Wang, Xiaowei ;
O'Keefe, Graeme J. ;
Tochon-Dansuy, Henri J. ;
Scott, Andrew M. ;
Ackermann, Uwe ;
Peter, Karlheinz ;
Donnelly, Paul S. ;
Hagemeyer, Christoph E. .
MOLECULAR PHARMACEUTICS, 2014, 11 (08) :2855-2863
[8]  
Anderson CJ, 2001, J NUCL MED, V42, P213
[9]  
Anderson CJ, 1998, J NUCL MED, V39, P1944
[10]   RETRACTED: The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu (Retracted article. See art no 3860745, 2018) [J].
Asabella, Artor Niccoli ;
Cascini, Giuseppe Lucio ;
Altini, Corinna ;
Paparella, Domenico ;
Notaristefano, Antonio ;
Rubini, Giuseppe .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014